SONN icon

Sonnet BioTherapeutics
SONN

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $130K invested in Sonnet BioTherapeutics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$58K
2
+$35.1K
3
+$28K
4
TRCT
Tower Research Capital (TRC)
New York
+$8.35K
5
CWA
Carolina Wealth Advisors
South Carolina
+$47

Top Sellers

1
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$58K
2
$35.1K
3
$28K
4
$8.91K
5
$95
6
$47
7
$7
8
$4
9
$3
10
–